Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imlygic and Radiation in Soft Tissue Sarcoma
NCT04599062Phase 2Active, not recruiting
- Start
- Sep 2020
- Primary completion
- Feb 2023
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of talimogene laherparepvec in soft tissue sarcoma (STS). Started Sep 2020; status: active, not recruiting.
02
Drugs
talimogene laherparepvec
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04599062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04599062.